Clinical association of miR-155-5p with breast cancer and its relevance for treatment with PARP inhibitors

被引：0

作者：

Pasculli, Barbara ^{[1
]}

Barbano, Raffaela ^{[1
]}

Fontana, Andrea ^{[1
]}

Biagini, Tommaso ^{[1
]}

Di Viesti, Maria Pia ^{[1
]}

Rendina, Michelina ^{[1
]}

Valori, Vanna Maria ^{[1
]}

Morritti, Maria ^{[1
]}

Bravaccini, Sara ^{[2
]}

Ravaioli, Sara ^{[2
]}

Maiello, Evaristo ^{[1
]}

Graziano, Paolo ^{[1
]}

Murgo, Roberto ^{[1
]}

Copetti, Massimiliano ^{[1
]}

Mazza, Tommaso ^{[1
]}

Fazio, Vito Michele ^{[1
]}

Esteller, Manel ^{[3
,4
,5
,6
]}

Parrella, Paola ^{[1
]}

机构：

[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy

[2] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy

[3] Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain

[4] Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain

[5] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain

[6] Univ Barcelona, Barcelona, Spain

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-1422

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1422

引用

页数：2

共 50 条

[31] Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease [J].

Divi, Srikanth N. ;

Markova, Dessislava Z. ;

Fang, Taolin ;

Guzek, Ryan ;

Kurd, Mark F. ;

Rihn, Jeffrey A. ;

Hilibrand, Alan S. ;

Anderson, David Greg ;

Vaccaro, Alexander R. ;

Schroeder, Gregory D. ;

Kepler, Christopher K. .

SPINE, 2020, 45 (09) :E499-E507

[32] lncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p [J].

Wang, Ye ;

Zhou, Bin ;

Yan, Liping ;

Wu, Jianhui ;

Xing, Zhijie ;

Zhang, Shaochun ;

Xiang, Fusheng .

EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)

[33] A novel SERS-lateral flow assay (LFA) tray for monitoring of miR-155-5p during pyroptosis in breast cancer cells [J].

Lu, Xiaoxia ;

Lu, Wenlong ;

Hua, Dong .

ANALYTICAL METHODS, 2024, 16 (24) :3878-3894

[34] MiR-155-5p regulates autophagy and apoptosis of glioma cells through RICTOR [J].

Guo, Zhao ;

Tian, Jing-Jie ;

Wang, Yao ;

Jiang, Lei ;

Chen, Yang ;

Dai, He-Jun ;

Wang, Lei ;

Zhang, Yi .

TRANSLATIONAL CANCER RESEARCH, 2024, 13 (10) :5509-5521

[35] NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer [J].

Wang, Yueyue ;

Yan, Lei ;

Zhang, Lingyu ;

Xu, Henan ;

Chen, Tiantian ;

Li, Yu ;

Wang, Haifeng ;

Chen, Sulian ;

Wang, Wenrui ;

Chen, Changjie ;

Yang, Qingling .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (03) :1043-1054

[36] PARP Inhibitors for Breast Cancer Treatment A Review [J].

Morganti, Stefania ;

Marra, Antonio ;

De Angelis, Carmine ;

Toss, Angela ;

Licata, Luca ;

Giugliano, Federica ;

Taurelli Salimbeni, Beatrice ;

Berton Giachetti, Pier Paolo Maria ;

Esposito, Angela ;

Giordano, Antonio ;

Bianchini, Giampaolo ;

Garber, Judy E. ;

Curigliano, Giuseppe ;

Lynce, Filipa ;

Criscitiello, Carmen .

JAMA ONCOLOGY, 2024, 10 (05) :658-670

[37] Advances in PARP inhibitors for the treatment of breast cancer [J].

Dizdar, Omer ;

Arslan, Cagatay ;

Altundag, Kadri .

EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (18) :2751-2758

[38] miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy [J].

Yu, Qiu ;

Xu, Xiao-Ping ;

Yin, Xin-Min ;

Peng, Xiang-Qun .

NEOPLASMA, 2021, 68 (01) :87-95

[39] An Overview of PARP Inhibitors for the Treatment of Breast Cancer [J].

Cortesi, Laura ;

Rugo, Hope S. ;

Jackisch, Christian .

TARGETED ONCOLOGY, 2021, 16 (03) :255-282

[40] PARP inhibitors for the treatment and prevention of breast cancer [J].

Vinayak S. ;

Ford J.M. .

Current Breast Cancer Reports, 2010, 2 (4) :190-197

← 1 2 3 4 5 →